Following the news this week of what appears to have been the first confirmed case of a Covid-19 reinfection, other researchers have been coming forward with their own reports. One in Belgium, another in the Netherlands. And now, one in Nevada.
What caught experts attention about the case of the 25-year-old Reno man was not that he appears to have contracted SARS-CoV-2 (the name of the virus that causes Covid-19) a second time. Rather, its that his second bout was more serious than his first.
Immunologists had expected that if the immune response generated after an initial infection could not prevent a second case, then it should at least stave off more severe illness. Thats what occurred with the first known reinfection case, in a 33-year-old Hong Kong man.
advertisement
Still, despite what happened to the man in Nevada, researchers are stressing this is not a sky-is-falling situation or one that should result in firm conclusions. They always presumed people would become vulnerable to Covid-19 again some time after recovering from an initial case, based on how our immune systems respond to other respiratory viruses, including other coronaviruses. Its possible that these early cases of reinfection are outliers and have features that wont apply to the tens of millions of other people who have already shaken off Covid-19.
There are millions and millions of cases, said Michael Mina, an epidemiologist at Harvards T.H. Chan School of Public Health. The real question that should get the most focus, Mina said, is, What happens to most people?
advertisement
But with more reinfection reports likely to make it into the scientific literature soon, and from there into the mainstream press, here are some things to look for in assessing them.
Whats the deal with the Nevada case?
The Reno resident in question first tested positive for SARS-CoV-2 in April after coming down with a sore throat, cough, and headache, as well as nausea and diarrhea. He got better over time and later tested negative twice.
But then, some 48 days later, the man started experiencing headaches, cough, and other symptoms again. Eventually, he became so sick that he had to be hospitalized and was found to have pneumonia.
Researchers sequenced virus samples from both of his infections and found they were different, providing evidence that this was a new infection distinct from the first.
What happens when we get Covid-19 in the first case?
Researchers are finding that, generally, people who get Covid-19 develop a healthy immune response replete with both antibodies (molecules that can block pathogens from infecting cells) and T cells (which help wipe out the virus). This is what happens after other viral infections.
In addition to fending off the virus the first time, that immune response also creates memories of the virus, should it try to invade a second time. Its thought, then, that people who recover from Covid-19 will typically be protected from another case for some amount of time. With other coronaviruses, protection is thought to last for perhaps a little less than a year to about three years.
But researchers cant tell how long immunity will last with a new pathogen (like SARS-CoV-2) until people start getting reinfected. They also dont know exactly what mechanisms provide protection against Covid-19, nor do they know what levels of antibodies or T cells are required to signal that someone is protected through a blood test. (These are called the correlates of protection.)
Why do experts expect second cases to be milder?
With other viruses, protective immunity doesnt just vanish one day. Instead, it wanes over time. Researchers have then hypothesized that with SARS-CoV-2, perhaps our immune systems might not always be able to prevent it from getting a toehold in our cells to halt infection entirely but that it could still put up enough of a fight to guard us from getting really sick. Again, this is what happens with other respiratory pathogens.
And its why some researchers actually looked at the Hong Kong case with relief. The man had mild to moderate Covid-19 symptoms during the first case, but was asymptomatic the second time. It was a demonstration, experts said, of what you would want your immune system to do. (The case was only detected because the mans sample was taken at the airport when he arrived back in Hong Kong after traveling in Europe.)
The fact that somebody may get reinfected is not surprising, Malik Peiris, a virologist at the University of Hong Kong, told STAT earlier this week about the first reinfection. But the reinfection didnt cause disease, so thats the first point.
The Nevada case, then, provides a counterexample to that.
What kind of immune response did the person who was reinfected generate initially?
Earlier, we described the robust immune response that most people who have Covid-19 seem to mount. But that was a generalization. Infections and the immune responses they induce in different people are heterogeneous, said Sarah Cobey, an epidemiologist and evolutionary biologist at the University of Chicago.
Older people often generate weaker immune responses than younger people. Some studies have also indicated that milder cases of Covid-19 induce tamer immune responses that might not provide as lasting or as thorough of a defense as stronger immune responses. The man in Hong Kong, for example, did not generate antibodies to the virus after his first infection, at least to the level that could be detected by blood tests. Perhaps that explains why he contracted the virus again just about 4 1/2 months after recovering from his initial infection.
In the Nevada case, researchers did not test what kind of immune response the man generated after the first case.
Infection is not some binary event, Cobey said. And with reinfection, theres going to be some viral replication, but the question is how much is the immune system getting engaged?
What might be broadly meaningful is when people who mounted robust immune responses start getting reinfected, and how severe their second cases are.
Are people who have Covid-19 a second time infectious?
As discussed, immune memory can prevent reinfection. If it cant, it might stave off serious illness. But theres a third aspect of this, too.
The most important question for reinfection, with the most serious implications for controlling the pandemic, is whether reinfected people can transmit the virus to others, Columbia University virologist Angela Rasmussen wrote in Slate this week.
Unfortunately, neither the Hong Kong nor the Reno studies looked at this question. But if most people who get reinfected dont spread the virus, thats obviously good news.
What happens when people broadly become susceptible again?
Whether its six months after the first infection or nine months or a year or longer, at some point, protection for most people who recover from Covid-19 is expected to wane. And without the arrival of a vaccine and broad uptake of it, that could change the dynamics of local outbreaks.
In some communities, its thought that more than 20% of residents have experienced an initial Covid-19 case, and are thus theoretically protected from another case for some time. That is still below the point of herd immunity when enough people are immune that transmission doesnt occur but still, the fewer vulnerable people there are, the less likely spread is to occur.
On the flip side though, if more people become susceptible to the virus again, that could increase the risk of transmission. Modelers are starting to factor that possibility into their forecasts.
A crucial question for which there is not an answer yet is whether what happened to the man in Reno, where the second case was more severe than the first, remains a rare occurrence, as researchers expect and hope. As the Nevada researchers wrote, the generalizability of this finding is unknown.
Read more:
Several have been reinfected with Covid-19. Here's what that means - STAT
- Eosinophil innate immune memory after bacterial skin infection promotes allergic lung inflammation - Science | AAAS - April 5th, 2025
- Researchers Discover mRNA Vaccines Leave Lasting Mark on the Immune System - SciTechDaily - April 5th, 2025
- Scientific Journeys: Uncovering how dioxins affect the immune system - National Institutes of Health (NIH) (.gov) - April 5th, 2025
- Oligodendroglial precursor cells modulate immune response and early demyelination in a murine model of multiple sclerosis - Science | AAAS - April 5th, 2025
- Measles can ravage the immune system and brain, causing long-term damage a virologist explains - The Conversation - April 5th, 2025
- Microscopic Instigators - The University of New Mexico - April 5th, 2025
- Changes in the immune index before and after surgery in urinary malignancy patients with AIDS - Nature - April 5th, 2025
- Non-immune targeting of CXCR3 compromises mitochondrial function and suppresses tumor growth in glioblastoma - Nature - April 5th, 2025
- 8 Supplements That Will Boost Your Immune System - Verywell Health - April 5th, 2025
- Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models - Nature - April 5th, 2025
- Redefining the immune landscape of hepatitis A virus infection - Nature - April 5th, 2025
- What Happens to Your Immune Health When You Take Vitamin C and Zinc Together? - Verywell Health - April 5th, 2025
- Diet Has A Major Impact On The Immune System - WorldHealth.net - April 5th, 2025
- Top 7 ways to boost your immune system - The Indian Express - April 5th, 2025
- Kinetics of pIgR and IgM immune responses in snakehead ( Channa argus ) to inactivated Aeromonas hydrophila via immersion and intraperitoneal... - April 5th, 2025
- What Is Man Flu? - Cleveland Clinic Health Essentials - April 5th, 2025
- Dynamics of T cell subpopulations and plasma cytokines during the first year of antineoplastic therapy in patients with breast cancer: the BEGYN-1... - April 5th, 2025
- Publication in npj Vaccines Reports Cross-reactive and Long-Lasting Immune Responses for self-amplifying mRNA (samRNA) COVID-19 Vaccine Booster... - April 5th, 2025
- 9 Supplements, Tonics, and Oils to Boost Immune Health - W Magazine - April 5th, 2025
- Preoperative pan-immuno-inflammatory values and albumin-to-globulin ratio predict the prognosis of stage IIII colorectal cancer - Nature - April 5th, 2025
- Systemic Lupus Erythematosus (Lupus) - Who gets it? | NIAMS - February 7th, 2025
- Systemic Lupus Erythematosus (Lupus) Basics - National Institute of ... - February 7th, 2025
- Long COVID: women at greater risk compared to men could immune system differences be the cause? - The Conversation - February 7th, 2025
- What is Pemphigus? Symptoms & Causes | NIAMS - February 7th, 2025
- How the immune system influences pancreatic cancer: New interactions provide therapeutic insights - Medical Xpress - February 7th, 2025
- Mitochondrias Secret Power Unleashed in the Battle Against Inflammation - SciTechDaily - February 7th, 2025
- WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis - Nature.com - February 7th, 2025
- The role of the behavioral immune system in the expression of short and long-term orientation in young Chilean men during the COVID-19 pandemic - BMC... - February 7th, 2025
- Harvard nutritionist eats these 5 foods to keep her 'immune system strong' and 'energy high' - CNBC - February 7th, 2025
- Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing - Nature.com - February 7th, 2025
- Personalized Therapeutic Vaccine Steers the Immune System to Fight Kidney Cancer | Newswise - Newswise - February 7th, 2025
- Identification of m6A methyltransferase-related WTAP and ZC3H13 predicts immune infiltrates in glioblastoma - Nature.com - February 7th, 2025
- Serotonin attenuates tumor necrosis factor-induced intestinal inflammation by interacting with human mucosal tissue - Nature.com - February 7th, 2025
- Identification of the immune infiltration and biomarkers in ulcerative colitis based on liquidliquid phase separation-related genes - Nature.com - February 7th, 2025
- FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy - Nature.com - February 7th, 2025
- Young Innovators: U of S researcher uses bat immune systems to find next generation therapies - Saskatoon Star-Phoenix - February 7th, 2025
- World Cancer Day 2025: Chronic stress, immune system, and cancer risk- How are these connected? - The Times of India - February 7th, 2025
- New research unlocks key to long-lasting immune response in cancer and chronic diseases - The Peter Doherty Institute for Infection and Immunity - February 7th, 2025
- Microbial Dynamics and Immune Response to NTHi in COPD - Physician's Weekly - February 7th, 2025
- MHE Week in Review RFK Jr. Spotlight - Managed Healthcare Executive - February 7th, 2025
- Psoriasis Basics: Overview, Symptoms, and Causes - January 27th, 2025
- Vitiligo Symptoms, Treatment & Causes | NIAMS - January 27th, 2025
- The Surprising Connection Between Obesity, Parasites, and Your Immune System - SciTechDaily - January 27th, 2025
- Versatile 69p spice that boosts immune system can go in soups, smoothies and milk - Express - January 27th, 2025
- How the skins secret immune system could lead to needle-free vaccines - Gavi, the Vaccine Alliance - January 27th, 2025
- Fevers link with a key kind of immunity is surprisingly ancient - Science News Magazine - January 27th, 2025
- Immunology - The Scientist - January 27th, 2025
- Opinion: Immune System And Ageing Why We Get More Vulnerable As We Age - ABP Live - January 27th, 2025
- 'Forever chemicals' (PFAS) may weaken immune function in children, leading to more frequent infections - U.S. Right to Know - January 27th, 2025
- Cellular Signals That Wreak Havoc in Sepsis are Revealed - LabRoots - January 27th, 2025
- New Combination Immunotherapy Targets Melanoma and Breast Cancer with Promising Results - Inside Precision Medicine - January 27th, 2025
- New Research in The Journal of Poultry Science: Trained Immunity Offers Novel Poultry Disease Prevention Strategies - PR Newswire - January 27th, 2025
- Scientists uncover how cancer cells hijack T-cells, making it harder for the body to fight back - Medical Xpress - January 27th, 2025
- MiNK Therapeutics Targets Immune Reconstitution to Combat - GlobeNewswire - January 27th, 2025
- Mitochondria may be a promising therapeutic target for inflammatory diseases - Medical Xpress - January 27th, 2025
- Explainer: What is Guillain-Barr Syndrome and how it affects the immune system - Mathrubhumi English - January 27th, 2025
- Yes, Some Vaccines Contain Aluminum. Thats a Good Thing. - The New York Times - January 27th, 2025
- You Are What You Eat? MD Breaks Down The Science Of The Gut Microbiome - mindbodygreen - January 27th, 2025
- Potential gamechanger: Researchers discover basis for immunotherapy-induced myocarditis - Healio - January 27th, 2025
- Ozempic and Wegovy may boost health, from addiction to dementia - BBC.com - January 27th, 2025
- Neutrophil diversity and function in health and disease - Nature.com - December 6th, 2024
- Harnessing the Power of the Immune System for Breast Cancer Treatment - Breast Cancer Research Foundation - December 6th, 2024
- Study Examines Neoantigen Landscapes and Their Role in Immunotherapy Efficacy - Consult QD - December 6th, 2024
- The 5 Best Teas to Support Your Immune System This Cold & Flu Season - EatingWell - December 6th, 2024
- Engineered immune cells may be able to tame inflammation - Medical Xpress - December 6th, 2024
- Hybrid model of tumor growth, angiogenesis and immune response yields strategies to improve antiangiogenic therapy - Nature.com - December 6th, 2024
- Opioids interfere with cancer immunotherapy, but another type of drug could help - Medical Xpress - December 6th, 2024
- RANKL cytokine restores thymus cells in old mice, reducing tumor growth and improving T cell immune response - Fierce Biotech - December 6th, 2024
- Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in... - December 6th, 2024
- Immuno-Oncology Strategic Industry Research Report 2023-2024 & 2030: Approval of Pembrolizumab (Keytruda) and Nivolumab (Opdivo), which Target... - December 6th, 2024
- Study cracks the cold case of immunotherapy resistance - News-Medical.Net - December 6th, 2024
- New immune therapy improves survival and reduces tumor burden in glioblastoma - News-Medical.Net - December 6th, 2024
- Identification of immune-related hub genes and potential molecular mechanisms involved in COVID-19 via integrated bioinformatics analysis - Nature.com - December 6th, 2024
- Immune Cell Breakthrough: Scientists Discover a Hidden Ally in the Fight Against Cancer - SciTechDaily - December 6th, 2024
- Rising temperatures impact the immune system of wild monkeys - Earth.com - December 6th, 2024
- Study declaring Alzheimer's to be a "brain disease" proven to be fabricated - Earth.com - December 6th, 2024
- Warming temperatures impact immune performance of wild monkeys, U-M study shows - University of Michigan News - December 6th, 2024
- New study explores heart risks of cancer immunotherapy - News-Medical.Net - December 6th, 2024
- 'Incredible' way to boost your immune system naturally and ward of colds and flu this winter - The Mirror - December 6th, 2024
- Tis the Season to Boost Your Immune System - Mix93.3 - December 6th, 2024